13 Surgery for Essential Tremor



10.1055/b-0039-171732

13 Surgery for Essential Tremor

Andres l. Maldonado-Naranjo, Joshua Golubovsky, Andre G. Machado


Abstract


Deep brain stimulation of the Ventral Intermedius Nucleus (Vim DBS) is approved by the Food and Drug Administration for the management of essential tremor (ET) or tremor associated with Parkinson’s disease. In this chapter we will focus on the treatment of ET and will describe the assessment of candidates for DBS, the operative procedure, post-operative management, risks and complication avoidance strategies. Indications are described, along with our patient selection process. The procedures for surgical planning including target and trajectory planning, the operative approach, intraoperative physiology and macroelectrode implantation are described.




13.1 Patient Selection


Patients considered for surgical treatment of Essential Tremor (ET) are evaluated by an interdisciplinary team with neurological examination, video recording, and brain MRI with gadolinium. Cases are then discussed in a multi-disciplinary conference to determine candidacy and discuss technical choices. Common criteria are listed in ▶ Table 13.1. Prerequisites for surgical treatment include a confirmed diagnosis of ET, 1 , 2 failure of medical treatment to reduce tremor meaningfully without intolerable side effects, and significant impairment of function and quality of life associated with tremor.























Table 13.1 Inclusion and exclusion criteria for Vim DBS

Indications


Red Flags


Confirmed diagnosis of ET


Cognitive and behavioral issues, unrealistic goals


Failure of medical treatment


Early disease, non-optimized medical therapy


Significant medication intolerance


Abnormal brain imaging, alternative diagnoses


Moderate to severe disability


Significant medical or surgical comorbidities



13.2 Preoperative Preparation


Once candidacy is finalized, the patient is scheduled for preoperative assessments aimed at reducing perioperative risks. Internal medicine assessment, cardiology or other medical specialties are requested as needed. Platelet anti-aggregation therapy, anticoagulation, and non-steroidal anti-inflammatory medications are stopped 7 to 10 days before surgery, or a warfarin-to-heparin bridge is initiated in high-risk individuals. A 1.5 or 3 Tesla gadolinium-enhanced volumetric MRI, with T1 -and T2-weighted images is obtained for planning. A high resolution, thin-cut CT scan with contrast is used when MRI is contraindicated. Due to the limited number of MRI sequences compatible with deep brain stimulation (DBS) systems, patients requiring frequent MRI imaging post DBS might not be appropriate candidates 3 , 4 although some DBS systems are now compatible with head as well as body MRIs under specific scanning conditions. It is necessary to consult the labeling of the specific DBS implant for MRI safety instructions.



13.2.1 Targeting


While it is commonplace to utilize both direct and indirect techniques for DBS targeting, commonly available 1.5 T or 3.0 T MRI sequences do not allow for visualization of individual thalamic nuclei parcellations. Therefore, thalamic targeting is dependent primarily on indirect targeting based on the posterior commissure, distance to the wall of the third ventricle and distance to the internal capsule. While it is possible to target the Vim nucleus of the thalamus in the first stereotactic cannulation for placement of the DBS lead, we often prefer to refine stereotactic localization by first targeting the ventrocaudal (Vc) nucleus, the primary sensory relay located posterior to Vim. The Vc is organized with the sensory representation of the face medially and the representation of the lower extremity laterally. The transition between Vc and Vim is typically located 2–4 mm anterior to the posterior commissure (PC) and the upper extremity representation in the Vc located approximately 10–11 mm lateral to the wall of the third ventricle. The bottom of the thalamus is typically at the level of the intercommissural plane. The first microelectrode recording pass can indicate the laterality in relation to the plan. If more tactile units corresponding to the face are identified, this is an indication that the pass was more medial than intended and if more units corresponding to the leg are identified, it suggests a more lateral pass. A second microelectrode recording (MER) pass can be made anteriorly to help define the Vc-Vim transition. The final electrode is typically placed 2–4 mm anterior to the estimated Vc-Vim transition and aimed at the physiological topography of the upper extremity. 5 Although we in general avoid transventricular trajectories 6 some patients require a transventricular approach due to large ventricles or other limitations such as vascular anatomy that narrows the options for trajectory planning. 5 , 7

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 11, 2020 | Posted by in NEUROSURGERY | Comments Off on 13 Surgery for Essential Tremor

Full access? Get Clinical Tree

Get Clinical Tree app for offline access